Trials / Completed
CompletedNCT00328523
TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)
Ezetimibe Together With Any Statin Cholesterol Enhancement
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,496 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
In patients with primary hypercholesterolemia treated with a statin and with ldl-c above the recommended target goal (esc 2003 recommendations ldl\>=1.15 g/l) to compare the efficacy and the safety of ezetrol added to ongoing statin and non drug therapeutic intervention (patient motivation on diet or physical activities or both).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK-0653, ezetimibe | |
| DRUG | Duration of Treatment: 3 months |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2006-01-01
- Completion
- 2006-01-01
- First posted
- 2006-05-22
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00328523. Inclusion in this directory is not an endorsement.